TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / SPONSORED ADS
Total 13F shares
83,738,771
Share change
-1,781,161
Total reported value
$1,305,516,960
Put/Call ratio
7.9%
Price per share
$15.59
Number of holders
343
Value change
-$26,107,913
Number of buys
145
Number of sells
168

Quarterly Holders Quick Answers

What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2025

As of 31 Dec 2025, TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by 343 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 83,738,771 shares. The largest 10 holders included Capital Research Global Investors, MORGAN STANLEY, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, GOLDMAN SACHS GROUP INC, D. E. Shaw & Co., Inc., UBS Group AG, FMR LLC, BRANDES INVESTMENT PARTNERS, LP, BlackRock, Inc., and RENAISSANCE TECHNOLOGIES LLC. This page lists 343 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.